Lv1
70 积分 2020-10-21 加入
PK/PD Evaluation of Antibody–Drug Conjugates with Enhanced Immune Effector Functions
1天前
待确认
Anti-Thymocyte Antibody Induced Mesangiolytic Nephritis
2天前
求助中
Topoisomerase I inhibitors: Challenges, progress and the road ahead
13天前
已完结
Dual-payload antibody–drug conjugates: Taking a dual shot
29天前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
1个月前
已完结
Collagen IV in Gould syndrome and Alport syndrome
1个月前
已完结
Structures of Three Classes of Anticancer Agents Bound to the Human Topoisomerase I−DNA Covalent Complex
1个月前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
1个月前
已完结
The Internalization and Intracellular Trafficking of ADCs
1个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
1个月前
已完结